Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Bild på Shai Mulinari. Privat bild.

Shai Mulinari

Docent och Forskare

Bild på Shai Mulinari. Privat bild.

Failure of responsive regulation? : Pharmaceutical marketing, corporate impression management and off-label promotion of enzalutamide in Europe

Författare

  • Shai Mulinari
  • Courtney Davis
  • Piotr Ozieranski

Summary, in English

“Responsive regulation” has been proposed to offset pharmaceutical industry illicit behaviour in areas such as drug marketing based on self- regulation backed up with threats of government sanctions. We explore the efficacy of responsive regulation by tracing recent investigations by the UK pharmaceutical industry self-regulatory authority into the firm Astellas’s illicit promotion of a top-selling prostate cancer drug. Using documentary data, we reveal a ruthless company culture reflected in the illicit, so-called off-label promotion across Europe and the deceptive “impression management” by company managers during the course of investigations in the UK. We argue for a more probing, adversarial and government-led regulatory approach instead of the self-regulatory approach that shields breaching companies from enforcement actions and associated public scrutiny.

Avdelning/ar

  • Sociologi

Publiceringsår

2021-05-06

Språk

Engelska

Sidor

69-80

Publikation/Tidskrift/Serie

Journal of White Collar and Corporate Crime

Volym

2

Issue

2

Dokumenttyp

Artikel i tidskrift

Förlag

SAGE Publications

Ämne

  • Other Social Sciences not elsewhere specified

Nyckelord

  • pharmaceutical industry
  • responsive regulation
  • self-regulation
  • corporate crime
  • off-label
  • marketing

Status

Published

Projekt

  • What can be learnt from the new pharmaceutical industry payment disclosures? A network and policy analysis of ties between companies and health professionals and organisations

ISBN/ISSN/Övrigt

  • ISSN: 2631-309X